DisclosuresDavid J. Muzina: Honoraria received for speaking, consultation and advisory board participation from AstraZeneca, GlaxoSmithKline and Pfizer. Research/educational grant support has been received from: Abbott Labs, AstraZeneca, Eli Lilly, GlaxoSmithKline, Novartis, Pfizer and Repligen Corp. Chinedu Momah: Former employee of Bristol-Myers Squibb. James M. Eudicone: Employee of Bristol-Myers Squibb. Andrei Pikalov: Employee of Otsuka America Pharmaceutical Inc. Robert D. McQuade: Employee of Otsuka Pharmaceutical Development & Commercialization, Inc. Ronald N. Marcus: Employee of Bristol-Myers Squibb. Raymond Sanchez: Former employee of Bristol-Myers Squibb. Berit X. Carlson: Employee of Bristol-Myers Squibb.
Aripiprazole monotherapy in patients with rapid-cycling bipolar I disorder: an analysis from a long-term, double-blind, placebo-controlled study
Version of Record online: 25 MAR 2008
© 2008 The Authors
International Journal of Clinical Practice
Volume 62, Issue 5, pages 679–687, May 2008
How to Cite
Muzina, D. J., Momah, C., Eudicone, J. M., Pikalov, A., McQuade, R. D., Marcus, R. N., Sanchez, R. and Carlson, B. X. (2008), Aripiprazole monotherapy in patients with rapid-cycling bipolar I disorder: an analysis from a long-term, double-blind, placebo-controlled study. International Journal of Clinical Practice, 62: 679–687. doi: 10.1111/j.1742-1241.2008.01735.x
Previous presentation Presented as a poster at the 7th International Conference on Bipolar Disorder (ICBD), 7–9 June 2007, Pittsburgh, Pennsylvania, USA.
Clinical trial registry information ClinicalTrial.gov Identifier NCT00036348.
Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.
- Issue online: 11 APR 2008
- Version of Record online: 25 MAR 2008
- Paper received November 2007, accepted February 2008
- 4Rapid-cycling bipolar disorder: reviewing the evidence for pharmacologic interventions. CNS News 2006; January: 27–32..
- 7Impact of misdiagnosis in dual diagnosis rapid cycling bipolar disorder. Bipolar Disord 2005; 7: 27–117, Abstract P66., , et al.